All In Biotech

Drug Trial Radar · NCT06325566

Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

A Prospective, Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Combined With HA in Subjects With Moderate to Severe Chronic Low Back Pain

Last checked: Nov 20, 2026Latest source record: Jun 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Jul 3, 2024

Primary completion

Jul 2027

Study completion Jul 2028

Sponsor

Lead sponsor
Mesoblast, Ltd.Industry
Sponsor type
Industry
First posted
Mar 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a single injection of rexlemestrocel-L+HA injected into a lumbar intervertebral disc compared to control through 12 months post-treatment.

Conditions

  • Degenerative Disc Disease

Interventions

  • Rexlemestrocel-L + HA mixtureDrug

    Rexlemestrocel-L will be combined in 1:1 by-volume ratio with HA solution and the resulting mixture will be administered as intradiscal injection.

  • SalineDrug

    Saline solution injection adjacent to the index disc.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Baseline in Daily Average Low Back Pain at 12 Months Post-treatment Based on Visual Analog Scale (VAS) ScoreTime frame: Baseline and Month 12
  2. Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: Up to Month 24

Locations

40 sites in 1 country. Site status is shown where the registry gives one.

  • Axsendo Clinical Research/Summa Pain Care

    Phoenix, Arizona

  • Pain Institute of Southern Arizona

    Tucson, Arizona

  • TriWest Research Associates

    Chula Vista, California

  • Boomerang Health Care

    Concord, California

  • Apex Research Group

    Fair Oaks, California

  • Memorial Orthopaedic Surgical Group

    Long Beach, California

  • Newport Therapeutics

    Newport Beach, California

  • University of California-Davis Spine Center

    Sacramento, California

  • Innovative Pain Treatment Solutions

    San Diego, California

  • University of California-San Francisco

    San Francisco, California

  • Source Healthcare

    Santa Monica, California

  • Colorado Spine Partners/The Denver Spine and Pain Institute

    Greenwood, Colorado

  • Cantor Spine Center at the Paley Orthopedic & Spine Institute

    Fort Lauderdale, Florida

  • New Life Medical Research Center

    Hialeah, Florida

  • Bold City Clinical Research

    Jacksonville, Florida

  • Interventional Pain Institute

    The Villages, Florida

  • Conquest Research LLC

    Winter Park, Florida

  • Emory Healthcare

    Dunwoody, Georgia

  • Vista Clinical Research

    Newnan, Georgia

  • Hawaii Pain & Spine

    Kailua, Hawaii

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Iqra Research

    Edgewood, Kentucky

  • Paradigm Health System

    Slidell, Louisiana

  • The Kahan Center

    Annapolis, Maryland

  • Elevate Clinical Research

    Rockville, Maryland

  • Oasis Clinical Research

    Las Vegas, Nevada

  • Reno Tahoe Pain Associates

    Reno, Nevada

  • University of Rochester

    Rochester, New York

  • Eximia EquiHealth Research LLC/Emerge Ortho

    Durham, North Carolina

  • AdventHealth Hendersonville

    Hendersonville, North Carolina

  • Meta Medical Research Institute, LLC

    Dayton, Ohio

  • Clinical Investigations, LLC

    Edmond, Oklahoma

  • OSS Health

    York, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • Clinical Trials of South Carolina

    Charleston, South Carolina

  • Institute of Precision Pain Medicine

    Corpus Christi, Texas

  • Paradigm Research Center/Houston Scoliosis and Spine Institute

    Houston, Texas

  • Axsendo Clinical Research/Texas Institute of Pain and Spine

    Pearland, Texas

  • VA iSpine Physicians

    Richmond, Virginia

  • West Virginia University

    Martinsburg, West Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.